JSPR Financials
Jasper Therapeutics Inc - Financial statements & key metrics
Stock Price
$1.05
Market Cap
$26.10M
EPS
$-4.09
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$0.00
Gross Profit
$-1.06M
Operating Income
$-80.52M
Net Income
$-75.80M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$35.78M
Total Liabilities
$31.63M
Shareholders Equity
$4.15M
Cash & Equivalents
$28.69M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-77.16M
CapEx
$7000
Free Cash Flow
$-77.17M
Profitability Metrics
ROE
-2.3%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is JSPR revenue?
JSPR's most recent quarterly revenue was $0.00. Annual revenue can be calculated by summing the four most recent quarters.
Is JSPR profitable?
JSPR reported a loss of $75.80M in the most recent quarter.
What is JSPR market cap?
JSPR has a market capitalization of $26.10M, making it a small-cap stock.
Does JSPR have debt?
View JSPR's balance sheet for debt information.
What is JSPR cash flow?
JSPR's most recent quarterly free cash flow was $-77.17M.